Cargando…
Targeted inhibition of ERα signaling and PIP5K1α/Akt pathways in castration‐resistant prostate cancer
Selective ERα modulator, tamoxifen, is well tolerated in a heavily pretreated castration‐resistant prostate cancer (PCa) patient cohort. However, its targeted gene network and whether expression of intratumor ERα due to androgen deprivation therapy (ADT) may play a role in PCa progression is unknown...
Autores principales: | Semenas, Julius, Wang, Tianyan, Sajid Syed Khaja, Azharuddin, Firoj Mahmud, AKM, Simoulis, Athanasios, Grundström, Thomas, Fällman, Maria, Persson, Jenny L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024724/ https://www.ncbi.nlm.nih.gov/pubmed/33275817 http://dx.doi.org/10.1002/1878-0261.12873 |
Ejemplares similares
-
The functional interlink between AR and MMP9/VEGF signaling axis is mediated through PIP5K1α/pAKT in prostate cancer
por: Larsson, Per, et al.
Publicado: (2019) -
Establishment of Prostate Tumor Growth and Metastasis Is Supported by Bone Marrow Cells and Is Mediated by PIP5K1α Lipid Kinase
por: Karlsson, Richard, et al.
Publicado: (2020) -
FcγRIIIa receptor interacts with androgen receptor and PIP5K1α to promote growth and metastasis of prostate cancer
por: Larsson, Per Flodbring, et al.
Publicado: (2022) -
PIP5K1α is Required for Promoting Tumor Progression in Castration-Resistant Prostate Cancer
por: Wang, Tianyan, et al.
Publicado: (2022) -
The role of PIP5K1α/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1α inhibitor
por: Sarwar, Martuza, et al.
Publicado: (2018)